Wei Cao1, Aiqing Li1, Jiawen Li1, Chunyi Wu1, Shuang Cui1, Zhanmei Zhou1, Youhua Liu1, Christopher S Wilcox2, Fan Fan Hou1. 1. 1 Division of Nephrology, Nanfang Hospital, Southern Medical University , State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Guangzhou, P.R. China . 2. 2 Hypertension, Kidney and Vascular Research Center, Georgetown University , Washington, District of Columbia.
Abstract
AIMS: A kidney-brain interaction has been described in acute kidney injury, but the mechanisms are uncertain. Since we recently described a reno-cerebral reflex, we tested the hypothesis that renal ischemia-reperfusion injury (IRI) activates a sympathetic reflex that interlinks the renal and cerebral renin-angiotensin axis to promote oxidative stress and progression of the injury. RESULTS: Bilateral ischemia-reperfusion activated the intrarenal and cerebral, but not the circulating, renin-angiotensin system (RAS), increased sympathetic activity in the kidney and the cerebral sympathetic regulatory regions, and induced brain inflammation and kidney injury. Selective renal afferent denervation with capsaicin or renal denervation significantly attenuated IRI-induced activation of central RAS and brain inflammation. Central blockade of RAS or oxidative stress by intracerebroventricular (ICV) losartan or tempol reduced the renal ischemic injury score by 65% or 58%, respectively, and selective renal afferent denervation or reduction of sympathetic tone by ICV clonidine decreased the score by 42% or 52%, respectively (all p < 0.05). Ischemia-reperfusion-induced renal damage and dysfunction persisted after controlling blood pressure with hydralazine. INNOVATION: This study uncovered a novel reflex pathway between ischemic kidney and the brain that sustains renal oxidative stress and local RAS activation to promote ongoing renal damage. CONCLUSIONS: These data suggest that the renal and cerebral renin-angiotensin axes are interlinked by a reno-cerebral sympathetic reflex that is activated by ischemia-reperfusion, which contributes to ischemia-reperfusion-induced brain inflammation and worsening of the acute renal injury. Antioxid. Redox Signal. 27, 415-432.
AIMS: A kidney-brain interaction has been described in acute kidney injury, but the mechanisms are uncertain. Since we recently described a reno-cerebral reflex, we tested the hypothesis that renal ischemia-reperfusion injury (IRI) activates a sympathetic reflex that interlinks the renal and cerebral renin-angiotensin axis to promote oxidative stress and progression of the injury. RESULTS: Bilateral ischemia-reperfusion activated the intrarenal and cerebral, but not the circulating, renin-angiotensin system (RAS), increased sympathetic activity in the kidney and the cerebral sympathetic regulatory regions, and induced brain inflammation and kidney injury. Selective renal afferent denervation with capsaicin or renal denervation significantly attenuated IRI-induced activation of central RAS and brain inflammation. Central blockade of RAS or oxidative stress by intracerebroventricular (ICV) losartan or tempol reduced the renal ischemic injury score by 65% or 58%, respectively, and selective renal afferent denervation or reduction of sympathetic tone by ICV clonidine decreased the score by 42% or 52%, respectively (all p < 0.05). Ischemia-reperfusion-induced renal damage and dysfunction persisted after controlling blood pressure with hydralazine. INNOVATION: This study uncovered a novel reflex pathway between ischemic kidney and the brain that sustains renal oxidative stress and local RAS activation to promote ongoing renal damage. CONCLUSIONS: These data suggest that the renal and cerebral renin-angiotensin axes are interlinked by a reno-cerebral sympathetic reflex that is activated by ischemia-reperfusion, which contributes to ischemia-reperfusion-induced brain inflammation and worsening of the acute renal injury. Antioxid. Redox Signal. 27, 415-432.
Authors: María T Grande; Gloria Pascual; Adela S Riolobos; Milagros Clemente-Lorenzo; Beatriz Bardaji; Luz Barreiro; Olga Tornavaca; Anna Meseguer; Jose M López-Novoa Journal: Free Radic Biol Med Date: 2011-08-25 Impact factor: 7.376
Authors: Manchang Liu; Yideng Liang; Srinivasulu Chigurupati; Justin D Lathia; Mikhail Pletnikov; Zhaoli Sun; Michael Crow; Christopher A Ross; Mark P Mattson; Hamid Rabb Journal: J Am Soc Nephrol Date: 2008-04-02 Impact factor: 10.121
Authors: Matthew A Sparks; Natalia A Makhanova; Robert C Griffiths; John N Snouwaert; Beverly H Koller; Thomas M Coffman Journal: Hypertension Date: 2012-11-12 Impact factor: 10.190
Authors: Lingli Li; En Yin Lai; Zaiming Luo; Glenn Solis; Margarida Mendonca; Kathy K Griendling; Anton Wellstein; William J Welch; Christopher S Wilcox Journal: Hypertension Date: 2018-11 Impact factor: 10.190
Authors: Shinji Tanaka; Chikara Abe; Stephen B G Abbott; Shuqiu Zheng; Yusuke Yamaoka; Jonathan E Lipsey; Nataliya I Skrypnyk; Junlan Yao; Tsuyoshi Inoue; William T Nash; Daniel S Stornetta; Diane L Rosin; Ruth L Stornetta; Patrice G Guyenet; Mark D Okusa Journal: Proc Natl Acad Sci U S A Date: 2021-03-23 Impact factor: 12.779